Management of lipids in patients with diabetes.
Barnett
Anthony
A
University of Birmingham, Birmingham Heartlands and Solihull NHS Trust, UK. anthony.barnett@heartsol.wmids.nhs.uk
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood* / Q000628:therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D012307:Risk Factors
D000924:Anticholesteremic Agents; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids